However, patients in the 10-17 years age group also showed the greatest improvement in appropriate prescription drug use compared to all other age groups over a four-year period.
As part of the partnership, the two companies will create a joint research team that will use big data and machine learning technology to develop therapeutic solutions and disease models.
A new report from the Pharmaceutical Research and Manufacturers of America is highlighting the large volume of cancer medicines and vaccines that are currently being developed, as well as the impact innovations have had on cancer death rates.
Customer-to-customer will be the next stage of business model evolution in healthcare, according to Frost & Sullivan.
The research found a 1% increase in overall prescription drug use was associated with decreases in non-prescription drug medical costs for three distinct groups of Medicaid beneficiaries.
The drug, which is indicated to treat fundal infections, is available in 50- and 200-mg dosage strengths.
Medisafe, a mobile health platform for medication management, on Tuesday announced its partnership with GoodRx, a prescription price comparison platform.
The acquisitions will bring InvaGen’s 32 products and 40 approved abbreviated new drug applications, as well as Exelan’s management team and institutional market under the company’s control.
Vernalis Therapeutics announced Tuesday that its Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended release syrup has been made available ahead of cold and flu season.
Data from recent years suggests that the increasing prevalence of diabetes may be leveling off.